|
|
Patient-specific therapy of glioblastoma using lightly-labeled [14C]-temozolomide
|
1R43CA134184-01
|
$102,900
|
$102,900
|
Arjomand, Ali
|
ACCIUM BIOSCIENCES, INC.
|
|
|
Clinical study of AdV-tk radiogene therapy for malignant glioma
|
5R44CA107745-04
|
$794,415
|
$794,415
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
|
RADIATION THERAPY ONCOLOGY GROUP
|
3U10CA021661-32S2
|
$9,611,397
|
$2,402,849
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
RADIATION THERAPY ONCOLOGY GROUP
|
3U10CA021661-32S3
|
$3,952
|
$988
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
RADIATION THERAPY ONCOLOGY GROUP
|
3U10CA021661-32S4
|
$80,640
|
$20,160
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Community Clinical Oncology Program Research Base
|
3U10CA037422-21S1
|
$27,801
|
$6,950
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Community Clinical Oncology Program Research Base
|
5U10CA037422-21
|
$1,665,362
|
$416,341
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
RTOG Tissue Bank
|
5U24CA114734-04
|
$793,026
|
$79,303
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Radiation Therapy Oncology Group-Statistical Center
|
3U10CA032115-26S1
|
$1,010,519
|
$252,630
|
Sadek, Ramses
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
American College of Radiology Imaging Network
|
2U01CA080098-10
|
$9,101,961
|
$910,196
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Molecular Target Focused Discovery of Anticancer Drugs
|
2R01CA090441-06A2
|
$381,250
|
$53,375
|
PETTIT, GEORGE
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-19
|
$481,201
|
$4,812
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
|
Infection and Inflammation in Adult Gliomas
|
1K07CA131505-01A1
|
$135,445
|
$135,445
|
SCHEURER, MICHAEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Study of Valproic Acid in Pediatric Brain Tumors
|
5K23CA113721-03
|
$135,036
|
$135,036
|
SU, JACK
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-25
|
$453,250
|
$4,533
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
|
Blood Flow MRI for Monitoring Glioma Angiogenesis
|
5R01CA115745-03
|
$335,708
|
$335,708
|
ALSOP, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
BIDMC Research Training Grant in Cancer Radiology
|
5T32CA059367-14
|
$139,719
|
$27,944
|
CLOUSE, MELVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Control of Protein Translation in Cancer Pathogenesis
|
7U01CA084292-10
|
$697,531
|
$348,766
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
SapC-DOPS Nanovesicles for Treating Glioblastoma Multiforme
|
1R43CA136017-01A1
|
$273,138
|
$273,138
|
Xu, Kevin
|
BEXION PHARMACEUTICALS, INC.
|
|
|
Meningioma: Risk Factors and Quality of Life
|
5R01CA109461-03
|
$224,348
|
$224,348
|
BLACK, PETER
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Signal Transduction Pathways in Glioblastoma
|
5R01CA108633-04
|
$445,200
|
$445,200
|
CHAKRAVARTI, ARNAB
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Dynamic Regulation of Ras via the NF1 tumor Suppressor
|
5R01CA111754-04
|
$280,637
|
$280,637
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Elucidating the role of the mTOR pathway in NF1-related tumorigenesis
|
5R01CA129814-02
|
$300,291
|
$300,291
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Physicians' Health Study II: Prevention Trial of Vitamins
|
5R01CA097193-07
|
$1,563,010
|
$312,602
|
GAZIANO, J
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Advanced Training in Surgical Oncology
|
5T32CA009535-23
|
$327,432
|
$65,486
|
IGLEHART, JAMES
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Multidisciplinary Training in Image-Guided Therapy
|
2R25CA089017-06A2
|
$538,479
|
$107,696
|
Jolesz, Ferenc
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Image Guided Therapy
|
5P01CA067165-10
|
$1,121,902
|
$560,951
|
Jolesz, Ferenc
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Controlled Functionalization of Composite Magnetic Nanoparticles for Targeted Del
|
5R21CA128529-02
|
$171,709
|
$171,709
|
Sun, Shouheng
|
BROWN UNIVERSITY
|
|
|
Ultra-HTP Multiplex Approach to Small Molecule Screens
|
1R43CA112827-01A2
|
$132,000
|
$132,000
|
MIELNICKI, LAWRENCE
|
BUFFALO MOLECULAR TARGET LABORATORY
|
|
|
Glycoproteins in Neural Cells and Cancer
|
5R01CA033895-26
|
$318,067
|
$318,067
|
FUKUDA, MINORU
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
|
MT1-MMP pericellular proteolysis in malignancy
|
5R01CA077470-11
|
$335,671
|
$83,918
|
STRONGIN, ALEX
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA030199-28
|
$3,649,220
|
$109,477
|
VUORI, KRISTIINA
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
|
NanoSystems Biology Cancer Center
|
5U54CA119347-04
|
$3,546,396
|
$1,063,919
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
|
Imaging of gene expression in glioblastoma
|
5R01CA109620-03
|
$277,775
|
$277,775
|
Basilion, James
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-18S3
|
$234,254
|
$7,028
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-19S1
|
$72,416
|
$2,172
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-19S2
|
|
$0
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-19
|
$5,104,000
|
$153,120
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Modulating Base Excision Repair in Tumor Drug Resistance
|
5R01CA086357-09
|
$261,129
|
$86,173
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Role of menin in islet cell biology and tumorigenesis
|
5K22CA103843-03
|
$155,250
|
$23,288
|
Scacheri, Peter
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Chemokine Secreting Dendritic Cells for Glioma Immunotherapy
|
5K08CA101954-03
|
$135,426
|
$135,426
|
SLOAN, ANDREW
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Tumor drug delivery systems based on polymalic acid
|
5R01CA123495-03
|
$274,041
|
$137,021
|
LJUBIMOVA, JULIA
|
CEDARS-SINAI MEDICAL CENTER
|
|
|
MECHANISMS FOR PITUITARY TUMORIGENESIS
|
5R01CA075979-10
|
$266,250
|
$266,250
|
MELMED, SHLOMO
|
CEDARS-SINAI MEDICAL CENTER
|
|
|
Targeting cancer stem cells for brain tumor therapy
|
1R21CA131999-01
|
$182,813
|
$182,813
|
YU, JOHN
|
CEDARS-SINAI MEDICAL CENTER
|
|
|
CANCER INFORMATION SERVICE
|
N02CO511011-010
|
$535,732
|
$10,179
|
YOUNG, JAMES
|
CENTURA HEALTH/ST THOMAS MORE HOSPITAL:1
|
|
|
GENOMIC ANALYSIS OF MEDULLOBLASTOMAS
|
5R01CA109467-05
|
$744,419
|
$744,419
|
POMEROY, SCOTT
|
CHILDREN'S HOSPITAL BOSTON
|
|
|
Brain tumor angiogenesis: Integrin ceramide signaling
|
5R01CA098568-05
|
$266,432
|
$266,432
|
ERDREICH-EPSTEIN, ANAT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
|
Molecular Studies of Down Syndrome Leukemia
|
5R01CA111778-04
|
$231,698
|
$231,698
|
PERENTESIS, JOHN
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
|
Schwann Cells in Neurofibromatosis Type 2 (NF2)
|
5R01CA118032-02
|
$285,000
|
$285,000
|
RATNER, NANCY
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
|
Neurobehavioral Late-Effects in Pediatric Brain Tumors
|
5R01CA112182-04
|
$492,333
|
$492,333
|
RIS, M
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Total relevant funding to Neurosciences Research for this search: $159,910,680
|
